✦ LIBER ✦

A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: β2-microglobulin associated with time to progression

✍ Scribed by Hiroto Ohguchi; Tomohiro Sugawara; Izumi Ishikawa; Mitsutaka Okuda; Yasuo Tomiya; Joji Yamamoto; Yasushi Onishi; Minami Fujiwara Yamada; Kenichi Ishizawa; Junichi Kameoka; Hideo Harigae

Publisher: Carden Jennings Publishing
Year: 2009
Tongue: English
Weight: 206 KB
Volume: 89
Category: Article
ISSN: 0925-5710
DOI: 10.1007/s12185-009-0279-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rapid early monoclonal protein reduction

Rapid early monoclonal protein reduction after therapy with bortezomib or bortezomib and pegylated liposomal doxorubicin in relapsed/refractory myeloma is associated with a longer time to progression

✍ Jatin Shah; Joan Bladé; Pieter Sonneveld; Jean-Luc Harousseau; Keith Lantz; Anil 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB

O21 A retrospective single-center experi

O21 A retrospective single-center experience with bortezomib-based therapy of relapsed and/or refractory multiple myeloma: survival results of our first 104 consecutive patients

✍ G. Mikala; A. Batai; I. Bodo; Z. Csukly; J. Dolgos; G. Halm; J. Janosi; B. Kapas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB